fbpx
Omer Akyol, MD, PhD

Omer Akyol, MD, PhD, is an Associate Research Investigator at The Texas Heart Institute's Molecular Cardiology Research Labs. He holds an MD from Ondokuz Mayis University, a Clinical Chemistry specialty from Ankara University, and a PhD in Medical Biology and Genetics from Firat University. Show full bio

Dr. Akyol’s research is innovative and driven by a deep interest in lipid metabolism’s impact on heart health. Focusing on lipoproteins, his work could transform cardiovascular health understanding and advance disease prevention and treatment. Dr. Akyol has also an extensive publication record and a history of delivering informative lectures to students at various academic levels.

See Publications

Texas Heart Institute Positions

Interests

  • Impact of electronegative lipoproteins on cardiovascular health

Education

  • Postgraduate:

    Department of Medical Biology and Genetics, Firat University, Elazig, Turkey

  • Medical School:

    Ondokuz Mayis University, Samsun, Turkey

  • Internship:

    Ondokuz Mayis University, Samsun, Turkey

  • Residency:

    Department of Biochemistry, Ankara University Medical School

  • Fellowships:

    Medical University of South Carolina, Charleston, SC

Academic & Clinical Affiliations

  • Hacettepe University, Ankara, Turkey

Publications

Vural, H., Armutcu, F., Akyol, O. et al. (2021). The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clin Chim Acta 523, 374–379. https://doi.org/10.1016/j.cca.2021.10.018.
Akyol, O., Tessier, K. and Akyol, S. (2021). Accuracy and uniformity of the nomenclature of biogenic amines and polyamines in metabolomics studies: A preliminary study. Biochem Mol Biol Educ 49, 441–445. https://doi.org/10.1002/bmb.21497.
Akyol, O., Chowdhury, I., Akyol, H. R. et al. (2020). Why are cardiovascular diseases more common among patients with severe mental illness? The potential involvement of electronegative low-density lipoprotein (LDL) L5. Med Hypotheses 142, 109821. https://doi.org/10.1016/j.mehy.2020.109821.
Akyol, S., Lu, J., Akyol, O. et al. (2017). The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications. Trends Cardiovasc Med 27, 239–246. https://doi.org/10.1016/j.tcm.2016.11.002.
Akyol, O., Akyol, S. and Chen, C.-H. (2016). Update on ADAMTS13 and VWF in cardiovascular and hematological disorders. Clin Chim Acta 463, 109–118. https://doi.org/10.1016/j.cca.2016.10.017.
Akyol, S., Kursunlu, S. F. and Akyol, O. (2016). Bone resorption, matrix metalloproteinases and caffeic acid phenethyl ester. Acta Orthop Traumatol Turc 50, 706–707. https://doi.org/10.1016/j.aott.2016.08.010.
Gurses, M. S., Ural, M. N., Gulec, M. A. et al. (2016). Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer’s Disease. Aging Dis 7, 479–490. https://doi.org/10.14336/AD.2016.0111.
Pehlivan, S., Gurses, M. S., Ural, M. N. et al. (2016). The Role of ADAMTS1 and Versican in Human Myocardial Infarction: A Postmortem Study. Lab Med 47, 205–212. https://doi.org/10.1093/labmed/lmw022.
Akyol, S., Yuksel, S., Pehlivan, S. et al. (2016). Possible role of antioxidants and nitric oxide inhibitors against carbon monoxide poisoning: Having a clear conscience because of their potential benefits. Med Hypotheses 92, 3–6. https://doi.org/10.1016/j.mehy.2016.04.015.
Erdemli, H. K., Akyol, S., Armutcu, F. et al. (2016). Melatonin and caffeic acid phenethyl ester in the regulation of mitochondrial function and apoptosis: The basis for future medical approaches. Life Sci 148, 305–312. https://doi.org/10.1016/j.lfs.2016.01.026.